Spine-Tech gets all-clear for spinal implant:
This article was originally published in Clinica
Spine-Tech's BAK/Proximity Interbody Fusion Implant has received marketing clearance from the FDA. Unlike the BAK implant, the BAK/Proximity implant is more porous and has concave sides. This is better for smaller patients as it allows the surgeon to place one of each type of implant closer together between the two vertebrae. The company is expecting to launch the product immediately.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.